DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $9,000 | – | 8,621 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,179,002 | $17,416,000 | 2.06% |
| Broadfin Capital, LLC | 7,660,100 | $10,954,000 | 1.15% |
| Rhenman & Partners Asset Management AB | 1,228,354 | $1,757,000 | 0.51% |
| Polar Capital LLP | 11,393,507 | $16,293,000 | 0.34% |
| Amici Capital, LLC | 6,334,100 | $9,058,000 | 0.30% |
| CLOUGH CAPITAL PARTNERS L P | 4,381,600 | $6,266,000 | 0.24% |
| FEDERATED HERMES, INC. | 34,115,000 | $48,784,000 | 0.16% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 17,675,041 | $25,275,000 | 0.15% |
| HOWARD HUGHES MEDICAL INSTITUTE | 433,557 | $620,000 | 0.14% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,044,375 | $1,493,000 | 0.07% |